Delta variant challenges China's costly lockdown strategy
BEIJING (AP) — The delta variant is challenging China’s costly strategy of isolating...
Stay updated with breaking news from Xi Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BEIJING (AP) — The delta variant is challenging China’s costly strategy of isolating...
Airport on 20 july. all flights from nanjing airport will be suspended for the next two weeks. dr xi chen is associate professor of public health at yale university. he told us exactly what is happening in nanjing. china has so far managed to keep the virus largely under control, as we know, by closing the borders and moving quickly to stamp out local outbreaks. but this time, nanjing authorities were slow in their identification of the virus. it was transmitted from an air flight from russia through airchina — airflight to nanjing onjuly10, but after ten days, the first identifying case of ...
Overexpression of PGC1 in vascular smooth muscle cells ameliorates atherosclerosis In a new study published in Circulation Research, Chen-Yu Zhang and Xiaohong Jiang's group from Nanjing University and Dongjin Wang's group from Nanjing Drum Tower Hospital reported a critical role of PGC1α in maintaining the contractile phenotype of vascular smooth muscle cells (VSMCs) and highlighted the therapeutic potential of PGC1α for atherosclerosis. The traditional view holds that aberrant proliferation of VSMCs promotes plaque formation after vessel injury and inflammation, whereas the presence of V...
2021 JUN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Daily -- Researchers detail new data in Information Technology - Data Visualization. According to news reporting originating in Wuhan, People’s Republic of China, by NewsRx journalists, research stated, “Data visualization has been increasingly important with the deployment of advanced
Chinese vaccine makers have chequered reputations Credit: Shutterstock China's drug authorities have given "conditional" approval for a second Covid-19 vaccine, Sinovac's CoronaVac jab - but the country could still be waiting until 2022 to reach herd immunity. The vaccine has already been rolled out to key groups at higher risk of exposure to coronavirus but Saturday's approval allows for its use on the general public. Fellow Chinese pharmaceutical company Sinopharm received a similar conditional green light in December to put its vaccine on the market. Chinese vaccine makers have chequered...